GlassScriptPhysician profile
Jack N Alpert
NPI 1346209327
$3,282.51
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,582 · 2020: $381 · 2021: $137 · 2022: $182.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $532.50 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $410.34 | 2019 | |
| Biogen, INC. | $262.75 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $188.65 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $183.00 | 2019-2020 | |
| Acorda Therapeutics, INC | $177.10 | 2019-2020 | |
| Emd Serono, INC. | $170.68 | 2019 | |
| Ucb, INC. | $154.84 | 2019-2021 | |
| Ge Healthcare | $133.39 | 2019 | |
| Genzyme Corporation | $120.82 | 2019-2020 | |
| Lilly USA, LLC | $120.78 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $120.72 | 2019-2020 | |
| Grifols USA, LLC | $117.43 | 2019 | |
| Neurocrine Biosciences, INC. | $103.63 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $50.79 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $45.23 | 2019 | |
| Upsher-Smith Laboratories LLC | $43.46 | 2019-2020 | |
| Sk Life Science, INC. | $42.66 | 2020-2021 | |
| Bausch Health US, LLC | $40.49 | 2019 | |
| Eisai INC. | $39.32 | 2019 | |
| Amneal Pharmaceuticals LLC | $38.88 | 2019-2020 | |
| Promius Pharma LLC | $34.22 | 2019 | |
| Avanir Pharmaceuticals, INC. | $29.55 | 2019 | |
| Amgen INC. | $27.31 | 2019 | |
| Jazz Pharmaceuticals INC. | $23.30 | 2019 | |
| Tanabe Pharma America, INC. | $20.23 | 2019 | |
| Harmony Biosciences LLC | $19.11 | 2020 | |
| Supernus Pharmaceuticals, INC. | $16.00 | 2019 | |
| Glaxosmithkline, LLC. | $15.33 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Alpert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.